High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy by Amadeo M. Parissenti, Laura B. Pritzker, Maria Aanesland Dahle, Hedda von der Lippe Gythfeldt, Twinkle Masilamani, Gabriel Theriault, Renée St-Onge, Lavina D’costa, Ole Christian Lingjaerde, Mads Haugland Haugen, Olav Engebraaten

Get full text